Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia

Keyphrases

• B-CLL 100%
• Genetic Aberrations 100%
• Genome-wide Microarray 100%
• Copy number Variation 100%
• Subclonal 100%
• Genome Complexity 50%
• In Cancer 50%
• Leukemia 50%
• Loss of Heterozygosity 50%
• Lymphoma 50%
• Poor Clinical Outcomes 50%
• Biological Significance 50%
• Therapeutic Strategies 50%
• Sequence Analysis 50%
• Clinical Significance 50%
• Statistical Tools 50%
• Paired Samples 50%
• Future Therapeutics 50%
• Aberrations 50%
• Array-based 50%
• Complex Change 50%
• Targeted Therapy 50%
• Chemotherapy Resistance 50%
• Driver Genes 50%
• Subclonal Architecture 50%
• CN-LOH 50%

Medicine and Dentistry

• B-Cell Chronic Lymphocytic Leukemia 100%
• Leukemia 50%
• Heterozygosity 50%
• Cancer 50%
• Targeted Therapy 50%

Biochemistry, Genetics and Molecular Biology

• Genomics 100%
• B Cell 100%
• Genetics 50%
• Loss of Heterozygosity 50%